SEATTLE, March 15 /CNW/ - Dr. Bojana Turic, Vice President, COO will
present on behalf of Perceptronix Medical Inc. ("Perceptronix") at the Invest
Northwest CEO & Investor Forum on March 20 at Bell Harbor International
Conference Center, Seattle, Washington. Organized by the Washington
Biotechnology & Biomedical Association (WBBA) in collaboration with BC
Biotech, BC Medtech, BioAlberta, BioIdaho, Montana Bioscience Alliance and the
Oregon Bioscience Association, Invest Northwest is in its sixth year.
The annual life science CEO and investor conference will include
presentations from 57 of the region's top medical device and biotechnology
companies. "I am looking forward to presenting along side such an outstanding
group of companies" says Dr. Turic. "The conference is not only an exciting
opportunity for us to inform investors on our business and platforms but it is
also an excellent forum to explore synergies with other companies."
About Perceptronix Medical Inc. (www.perceptronix.com)
Perceptronix Medical Inc. (founded in 1999) is a private cancer
diagnostics company based in Vancouver, Canada. Perceptronix commercializes
early cancer detection technologies developed in partnership with the BC
Cancer Agency, a world-leader in cancer care and research, with a particularly
notable track record in pioneering early cancer detection programs.
Perceptronix' products and services offer an improvement over existing
detection and localization technologies and provide physicians with increased
options for prolonging and improving the quality of patients' lives.
About Invest Northwest
To qualify as a presenting company, a firm must be based in the Pacific
Northwest and have biosciences as its business base. Invest Northwest is a
forum for senior executives from selected public and private life sciences
companies based in the Pacific Northwest to tell their stories to
institutional investors, analysts, investment bankers, fund managers, venture
capitalists, angel investors and prospective corporate partners. More than 500
people are expected to attend the forum, now in its sixth year. For more
information, visit www.washbio.org.
This news release is not, and under no circumstances, to be construed as,
an advertisement, solicitation or offering of securities of Perceptronix
Medical Inc. The statements made in this news release may contain certain
forward-looking statements that involve a number of risks and uncertainties.
Actual events or results may differ from the Company's expectations.
For further information:
For further information: Dr. Bojana Turic, Vice President, COO
Perceptronix Medical Inc., Phone: (604) 629-8785, email@example.com; Media
Contact: Amanda Smith, BSc, Smith Biotech, Phone: (778) 846-4116,